Systemic Adrenocorticotropic Hormone Administration Down-Regulates the Expression of Corticotropin-Releasing Hormone (CRH) and CRH-Binding Protein in Infant Rat Hippocampus

Pediatric Research

Volumn 55, Issue 4, 2004, Pages 604-610

  Wang, Wei ^a   Murphy, Bridgid ^a   Dow, Kimberly E ^a   Andrew, R David ^a   Fraser, Douglas D ^b,c  

^a QUEEN S UNIVERSITY   (Canada)

^b CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^c CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; DRUG EFFICACY; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT DISEASE; INFANTILE SPASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; CARRIER PROTEINS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOWN-REGULATION; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 1642570437     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000112105.33521.DC     Document Type: Article

References (57)

1. Baram TZ 1993 Pathophysiology of massive infantile spasms: perspectives on the putative role of the brain adrenal axis. Ann Neurol 33:231-236
2. Ottaviani E, Franchini A, Genedani S 1999 ACTH and its role in immuneneuroendocrine functions. A comparative study. Curr Pharm Des 5:673-681
3. Arai M, Widmaier EP 1993 Steroidogenesis in isolated adrenocortical cells during development in rats. Mol Cell Endocrinol 92:91-97
4. Dallman MF 2000 Editorial: moments in time - the neonatal rat hypothalamo-pituitary-adrenal axis. Endocrinology 141:1590-1592
5. Vazquez DM 1998 Stress and the developing limbic-hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 23:663-700
6. Baram TZ, Hatalski CG 1998 Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21:471-476
7. Gaza CC, Sankar R 1998 Pathogenesis of the developmental epilepsies. Curr Opin Pediatr 10:567-574
8. Watanabe K 1998 West syndrome: etiological and prognostic aspects. Brain Dev 20:1-8
9. Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ 2001 Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol 49:304-312
10. Smith R 1999 The timing of birth. Sci Am 3:68-75
11. Dobbing J, Sands J 1973 Quantitative growth and development of human brain. Arch Dis Child 48:757-767
12. Graham YP, Heim C, Goodman SH, Miller AH, Nemeroff CB 1999 The effects of neonatal stress on brain development: implications for psychopathology. Dev Psychopathol 11:545-565
13. Aldenhoff JB, Goul DM, Rivier J, Vale W, Siggins GR 1983 Corticotropin-releasing factor decreases postburst hyperpolarization and excites hippocampal neurons. Science 221:875-877
14. Smith B, Dudek FE 1994 Age-related epileptogenic effects of corticotropin-releasing hormone in the isolated CA1 region of rat hippocampal slices. J Neurophysiol 72:2328-2333
15. Hollrigel GS, Chen K, Baram TZ, Soltesz I 1998 The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 84:71-79
16. sAHP, by the neuropeptides CRF, VIP and CGRP in hippocampal pyramidal neurons. J Neurophysiol 83:2071-2079
17. Alves SE, Akbari HM, Anderson GM, Azmitia EC, McEwen BC, Strand FL 1997 Neonatal ACTH administration elicits long-term changes in forebrain monoamine innervation. Subsequent disruptions in hypothalamic-pituitary-adrenal and gonadal function. Ann N Y Acad Sci 814:226-251
18. Wang W, Dow KE, Fraser DD 2001 Elevated corticotrophin releasing hormone/corticotropin releasing hormone-R1 expression in postmortem brain obtained from children with generalized epilepsy. Ann Neurol 50:404-409
19. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
20. Mulchahey JJ, Regmi A, Sheriff S, Balasubramaniam A, Kasckow JW 1999 Coordinate and divergent regulation of corticotrophin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line. Endocrinology 140:251-259
21. Behan DP, Maciejewski D, Chalmers D, DeSouza EB 1995 Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res 698:259-264
22. Fraser DD, MacVicar BA 1996 Cholinergic-dependent plateau potential in hippocampal CA1 pyramidal neurons. J Neurosci 16:4112-4128
23. Fraser DD, Doll D, MacVicar BA 2001 Serine/threonine protein phosphatases and synaptic inhibition regulate the expression of cholinergic-dependent plateau potentials. J Neurophysiol 85:1197-1205
24. Baram TZ, Shultz L 1995 ACTH does not control neonatal seizures induced by administration of exogenous corticotrophin-releasing hormone. Epilepsia 36:174-178
25. Sakanaka M, Shibasaki T, Lederis K 1987 Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine. J Comp Neurol 260:256-298
26. Yan XX, Toth Z, Schultz L, Ribak CE, Baram TZ 1998 Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylate and parvalbumin. Hippocampus 8:231-243
27. Pich EM, Lorang M, Yegeneh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F 1995 Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447
28. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H 1998 Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18:4758-4766
29. Smith MA, Weiss SR, Berry RL, Zhang LX, Clark M, Massenburg G, Post RM 1997 Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res 745:248-256
30. Piekut DT, Phipps B 1999 Corticotropin-releasing factor immunolabeled fibers in brain regions with localized kainate neurotoxicity. Acta Neuropathol 98:622-628
31. Masui JS, Morinobu S, Takahashi Y, Tsunashima K, Noda A, Yamada N, Kato N 1999 Elevated neuropeptide Y and corticotropin-releasing factor in the brain of a novel epileptic mutant rat: Noda epileptic rat. Brain Res 833:286-290
32. Siggins GR, Groul D, Aldenhoff J, Pittman Q 1985 Electrophysiological actions of corticotropin-releasing factor in the central nervous system. Fed Proc 44:237-242
33. Rannie DG, Fernhout JH, Schinnick-Gallagher P 1992 Differential actions of corticotropin-releasing factor on basolateral and central amygdaloid neurons, in vitro. J Pharmacol Exp Ther 263:846-858
34. Baram TZ, Shultz L 1991 Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61:97-101
35. Baram TZ, Ribak CE 1995 Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. Neuroreport 6:277-280
36. Watson SJ, Richard CW III, Barchas JD 1978 Adrenocorticotropin in rat brain: immunocytochemical localization in cells and axons. Science 200:1180-1182
37. Chen Y, Bender RA, Frotscher M, Baram TZ 2001 Novel and transient populations of corticotrophin-releasing hormone - expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci 21:7171-7181
38. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW 1992 The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRH. Proc Natl Acad Sci U S A 89:4192-4196
39. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW 1995 Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRH and related peptides. Front Neuroendocrinol 16:362-382
40. Mulchahey JJ, Regmi A, Sheriff S, Balasubramaniam A, Kasckow JW 1999 Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line. Endocrinology 140:251-259
41. McCarthy JR, Heinrichs SC, Grigoriadis DE 1999 Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 5:289-315
42. Adan RAH, Gispen WH 2000 Melanocortins and the barin: from effects via receptors to drug targets. Eur J Pharmacol 405:13-24
43. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD 1994 Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1293-1308
44. Adan RAH, Cone RD, Burbach JPH, Gispen WH 1994 Differential effects of melanocortin peptides on neural melanocortin receptors. Mol Pharmacol 46:1182-1190
45. De Kloet ER, Vreugdenhil E Oitzl MS, Joëls M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
46. Edwards HE, Burnham WM 2001 The impact of corticosteroids on the developing animal. Pediatr Res 50:433-440
47. Joëls M 2000 Modulatory actions of steroid hormones and neuropeptides on electrical activity in brain. Eur J Pharmacol 405:207-216
48. Fraser DD, Whiting S, Andrew RD, MacDonald EA, Musa-Veloso K, Cunnane SC 2003 Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60:1026-1029
49. Snead OC III, Benton JW, Hosey LC, Swann JW, Spink D, Martin D, Rej R 1989 Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol. Neurology 39:1027-1031
50. Baram TZ, Mitchell WG, Tourney A, Snead OC, Hanson RA, Horton EJ 1996 High-dose corticotrophin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 97:375-379
51. Prasad AN, Stafstrom CF, Holmes GL 1996 Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids. Epilepsia 37:S81-S95
52. Sinclair DB 2003 Prednisone therapy in pediatric epilepsy. Pediatr Neurol 28:194-198
53. Rogawski MA, Reddy DS 2002 Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis. Int Rev Neurobiol 49:199-219
54. A receptor function and seizure susceptibility. J Neurosci 22:3795-3805
55. Taylor CP 1999 Mechanisms of new antiepileptic drugs. Adv Neurol 79:1011-1026
56. Koo B 1999 Vigabatrin in the treatment of infantile spasms. Pediatr Neurol 20:106-110
57. Dimova PS, Korinthenberg R 1999 Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood. Pediatr Neurol 21:802-807